ong-term co-administration study of OPC-262 in patients with type 2 diabetes mellitus
Phase 3
- Conditions
- type 2 diabetes
- Registration Number
- JPRN-jRCT2080221215
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1) Patients who are capable of giving informed consent
2) Patients who are able to take contraceptive measures to avoid pregnancy of the patient or the patient's partner
Exclusion Criteria
Patients with severe ketosis, diabetic coma or precoma, or type 1 diabetes mellitus
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety
- Secondary Outcome Measures
Name Time Method HbA1c<br>Change from baseline in HbA1c